Natco Pharma’s marketing partner BPI obtains FDA approval for new drug

By Nikita Chaurasia  Date: 2021-03-10

Natco Pharma’s marketing partner BPI obtains FDA approval for new drug

Breckenridge Pharmaceutical Inc. (BPI), a marketing partner of Natco Pharma, has reportedly received U.S. Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application of Everolimus drug tablets.

The drug is basically a generic version of Afinitor and is primarily used for breast cancer treatment, as well as for treating other types of cancer. Sources confirmed that BPI is planning to launch tablets of 7.5 mg, 5 mg, and 2.5 mg strengths in the upcoming weeks.

The company will reportedly launch its 10 mg strength drugs after a licensing agreement and settlement with the owner of the Afinitor brand. A representative from Natco Pharma commented that the launch will be announced at a later date.

For those unaware, Breckenridge Pharmaceutical Inc. is a subsidiary of Japan-based Towa Pharmaceutical Co. Ltd. The company is headquartered in Berlin, Connecticut, and manufactures, distributes as well as markets over 82 pharmaceutical drugs in the U.S.

It has more than 40 Abbreviated New Drug Applications (ANDA) approved by the Food and Drug Administration and manufactures drugs in several categories including capsules, tablets, liquids, ophthalmics, transdermal patches, powders, nasal sprays, and injectable products.

BPI has partnered with manufacturers from across the world and aims to provide generic pharmaceuticals that are affordable and cost-effective to U.S. patients.

Recently, another Hyderabad-based drug maker, MSN Group, which also has a marketing partnership with BPI, announced that it had received final approval from USDA for its ANDA for Asenapine Sublingual Tablets.

MSN had earlier received final approval for 10 mg and 2.5 mg strengths of the same drug. The product will be launched by its marketing partner Breckenridge Pharmaceutical. The approved product is a generic version of Saphris and is employed for the treatment of bipolar disorder and schizophrenia.

According to MSN, Asenapine had recorded annual sales of USD 239 million during the year ending in September 2020.

Source Credits –

https://www.thehindu.com/business/natco-pharma-marketing-partner-bpi-gets-usfda-nod-for-anti-cancer-drug/article34022425.ece

 

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

BMW Group to opt for green steel in vehicle production from 2025

BMW Group to opt for green steel in vehicle production from 2025

By Nikita Chaurasia

As climatic changes and other environmental issues take center stage, the BMW Group, to minimize carbon dioxide (CO2) emissions at the core of its supply chain, has reportedly agreed to use green steel from Swedish firm H2 Green Steel beginning in 20...

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

By Nikita Chaurasia

Tech giant Apple, Inc. has recently unveiled the 16-inch MacBook Pro, which promises extraordinary design and performance. The model can be customized with the all-new M1 Pro and M1 Max processors.    These new 10-core processors are ...

Kedrion Biopharma expands to North America with Prometic acquisition

Kedrion Biopharma expands to North America with Prometic acquisition

By Nikita Chaurasia

Prometic Life Sciences has developed the first FDA-approved treatment for Congenital Plasminogen Deficiency. This acquisition will enable easy access to advanced therapies for patients suffering from this rare disease. Kedrion Biopharma Inc. has...

Facebook Pages to reduce focus on Likes and followers for Indian users

Facebook Pages to reduce focus on Likes and followers for Indian users

By Nikita Chaurasia

Facebook Inc. has reportedly removed Likes from Facebook Pages for its Indian users to make the platform more user-friendly and easier to understand. This redesign of Facebook Pages was launched in January 2021 and has been rolled out for Indian user...

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

By Nikita Chaurasia

India is likely to witness a record number of IPOs this year, with several companies eyeing public listing to raise funds if the market sentiment remains positive. One such company, Pine Labs is reportedly planning to list itself on Nasdaq by October...